Nuvectis Pharma, Inc.
NVCT
$6.49
-$0.38-5.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.90% | 53.43% | -3.10% | -22.17% | -26.36% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.58% | 13.60% | 25.42% | -32.02% | -46.63% |
| Total Current Assets | 47.60% | 52.93% | -3.01% | -22.26% | -26.63% |
|
|
|||||
| Total Current Assets | 47.60% | 52.93% | -3.01% | -22.26% | -26.63% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 47.60% | 52.93% | -3.01% | -22.26% | -26.63% |
|
|
|||||
| Total Accounts Payable | 169.61% | 70.10% | -9.85% | -35.25% | 2.38% |
| Total Accrued Expenses | 29.54% | 50.06% | 51.82% | 94.58% | 63.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 75.65% | 61.52% | 27.35% | 13.27% | 25.19% |
|
|
|||||
| Total Current Liabilities | 75.65% | 61.52% | 27.35% | 13.27% | 25.19% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 75.65% | 61.52% | 27.35% | 13.27% | 25.19% |
|
|
|||||
| Common Stock & APIC | 35.04% | 37.40% | 24.85% | 21.27% | 21.42% |
| Retained Earnings | -35.11% | -34.51% | -35.03% | -40.68% | -50.55% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 34.67% | 49.44% | -20.39% | -34.13% | -38.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.67% | 49.44% | -20.39% | -34.13% | -38.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 34.67% | 49.44% | -20.39% | -34.13% | -38.38% |
|
|
|||||